Quicksilver Scientific

Free Shipping on Orders over $99 (Excludes )

0
0
Subtotal: 0.00

No products in the cart.

G.I. Detox Box References

Artemisinin References https://www.quicksilverscientific.com/artemisinin-emulsion-references/

  1. Liu CX. Chinese Herbal Medicines. 2017 Apr;9(2): 101-114
  2. Rodriguez E, et al. Phytochemistry. 1976 Jan;15:1573-80
  3. Brown, G. Education in Chemistry. 2006:43(4): 97–99.
  4. Meshnick SR. Int J Parasitol.2002 Dec;32:1655-60.
  5. Sun C, et al. Microb Cell. 20152:14–25
  6. Pandey AV et al. Jour BiolChem 1999 274: 19383-19388.
  7. Hendley E.C. J. Am. Chem. Soc. 1948;70:3921–3924
  8. Cowan M.M. Clin. Microbiol. Rev. 1999;12:564–582.
  9. Liu CX. Chinese Herbal Medicines, 2017, 9(2): 101-114
  10. Cremer K, et al. Antimicrob Agents Chemother. 2015 Jan;59(1):421-6.

 

BitterX References https://www.quicksilverscientific.com/bitterxreferences/

  1. Klaassen CD, Aleksunes LM. Xenobiotic, bile acid, and cholesterol transporters: Function and regulation. Pharm Rev. 2010; 62(1): 1096.
  2. Garcia M, et al. Nuclear receptor metabolism of bile acids and xenobiotics: A coordinated detoxification system with impact on health and diseases. Int J Mol Sci. 2018; 19(11): 3630.
  3. Pan X, Jeong H. Estrogen-induced cholestasis leads to repressed CYP2D6 expression in CYP2D6-humanized mice. Mol Pharmacol. 2015; 88(1): 106-112.
  4. Chan KM, et al. De novo endotoxin-induced production of antibodies against the bile salt export pump associated with bacterial infection following major hepatectomy. BioMed Res Int. 2018; 2018: 6197152.
  5. Urdaneta V, Casadesus J. Interactions between bacteria and bile salts in the gastrointestinal and hepatobiliary tracts. Front Med. 2017. 4: 163.
  6. Sanchez LM, et al. Biofilm formation and detachment in gram-negative pathogens is modulated by select bile acids. PLoS One. 2016; 11(3): e0149603.
  7. Green RM, et al. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology. 1996; 111(1): 193-198.
  8. Gonzalez-Castejon M, et al. Diverse biological activities of dandelion. Nutr Rev. 70(9): 534-547.
  9. Liu B, et al. Taraxasterol inhibits LPS-induced inflammatory response in BV2 microglia cells by activating LXRα. Front Pharmacol. 2018; 9: 278.
  10. Esatbeyoglu T, et al. Sesquiterpene lactone composition and cellular Nrf2 induction of Taraxacum officinale leaves and roots and Taraxinic Acid β-d-Glucopyranosyl Ester. J Med Food. 2017; 20(1): 71-78.
  11. Tang X, et al. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice. J Ethnopharmacol. 2016; 194(24): 63-71.
  12. Mirzaee F, et al. Medicinal, biological and phytochemical properties of Gentiana species. J Tradit Complement Med. 2017; 7(4): 400-408.
  13. Yamada H, et al. Gentiolactone, a secoiridoid dilactone from Gentiana triflora, inhibits TNF-α, iNOS and Cox-2 mRNA expression and blocks NF-κB promoter activity in murine macrophages. PLoS One. 2014; 9(11): e113834.
  14. Chodera A, et al. Effect of flavonoid fractions of Solidago virgaurea L on diuresis and levels of electrolytes. Acta Pol Pharm. 1991; 48(5-6): 35-37.
  15. Apati P, et al. In-vitro effect of flavonoids from Solidago canadensis extract on glutathione S-transferase. J Pharm Pharmacol. 2006; 58(2): 251-256.
  16. Toiu A, et al. Solidago graminifolia L. Salisb. (Asteraceae) as a valuable source of bioactive polyphenols: HPLC profile, in vitro antioxidant and antimicrobial potential. Molecules. 2019; 24(14): 2666.
  17. Deng R, et al. The hypolipidemic agent guggulsterone regulates the expression of human bile salt export pump: dominance of transactivation over farnesoid X receptor-mediated antagonism. J Pharmacol Exp Ther. 2007; 320(3): 1153-1162.
  18. Sarup P, et al. Pharmacology and phytochemistry of oleo-gum resin of Commiphora wightii (Guggulu). Scientifica (Cairo). 2015; 2015: 138039.
  19. Ahn H, Park JH. Liposomal delivery systems for intestinal lymphatic drug transport. Biomater Res. 2016; 20: 36.
  20. Alyautdin R, et al. Nanoscale drug delivery systems and the blood-brain barrier. Int J Nanomedicine. 2014; 9: 795-811.
  21. Spector AA, Yorek MA. Membrane lipid composition and cellular function. J Lipid Res. 1985; 26(9): 1015-1035.

 

Ultra Binder® References https://www.quicksilverscientific.com/ultrabinderreferences/

  1. Meance SE. Acacia gum (Fibregum™), a very well tolerated specific natural prebiotic having a wide range of food applications-Part 1. Agro Food Industry Hi Tech. 2004 Jan 1;15(1):24-9.

  2. Liu G, Chen S et al. Chitosan modulates inflammatory responses in rats infected with enterotoxigenic Escherichia coli. Med. Inflamm. 2016:7432845

  3. Vaziri ND, Yuan J et al .Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption. Am J Nephrol 2013;37;518-525

  4. Sánchez Á, MengíbarM  et al. Influence of preparation methods of chitooligosaccharides on their physiochemical properties and their anti-inflammatory effects in mice and in RAW264.7 macrophages. Mar Drugs. 2018 Nov 2;16(11).

  5. Langmead L, Makins RJ et al. Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro. Aliment Pharmacol Ther. 2004 Mar 1;19(5):521-7.

  6.  Im SA, Lee YR et al. In vivo evidence of the immunomodulatory activity of orally administered Aloe vera gel. Arch Pharm Res. 2010 Mar;33(3):451-6

  7. Canani RB, Costanzo MD et al. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol. 2011 Mar 28;17(12):1519-28

  8. Suthongsa S, Pichyangkura R et al.  Effects of dietary levels of chito-oligosaccharide on ileal digestibility

    of nutrients, small intestinal morphology and crypt cell proliferation in weaned pigs. Livest. Sci. 2017: 198, 37–44.

  9. Neuvonen PJ, Olkkola KT. Oral activated charcoal in the treatment of intoxications: role of single and repeated doses Med Toxicol, 1988: 3: 33-58

  10. Bhatti SA, Khan MZ et al. Protective role of bentonite against aflatoxin B1- and ochratoxin A-induced immunotoxicity in broilers. J Immunotoxicol. 2017 Dec;14(1):66-76

  11. Li X, Wu P et al. Carbohydrate functionalized chitosan fiber for influenza virus capture. Biomacromolecules 2011: 12: 3962–3969

  12. Guan G, Azad MAK e al. Biological effects and applications of chitson and chito-oligosaccharides. Front Physiol. 2019: 10.3389/fphys.2019.00516

  13. Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients. 2013 Apr 22;5(4):1417-35

  14. Frolis VV, Nikolav VG et al. Effect of enteroabsorption on animal lifespan. Biomat. Art. 1989. 17(3): 341-351.

  15. Fields, H. The gut: where bacteria and the immune system meet. Available at: https://www.hopkinsmedicine.org/research/advancements-in-research/fundamentals/in-depth/the-gut-where-bacteria-and-immune-system-meet  [Accessed July 29, 2019]

  16. Su W, Ding X. Methods of endotoxin detection. J Lab Autom. 2015 Aug;20(4):354-64

  17. Goto T, Makinose S et al. Plasma endotoxin concentrations in patients with urinary tract infections Int J Urol. 1995 Sep;2(4):238-42

  18. Meghji S, Qureshi W et al. The role of endotoxin and cytokines in the pathogenesis of odontogenic cysts. Arch Oral Biol. 1996 Jun;41(6):523-31

  19. Ghoneim RH, Piquette-Miller M et al. Endotoxin-mediated downregulation of hepatic drug transporters in HIV-1 transgenic rats. Drug Metab Dispos. 2016 May;44(5):709-19

  20. Fukui H. Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia. World J Hepatic. 2015 Mar 27;7(3):425-42

  21. Mancini A, Campagna F et al. Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy. Food Funk. 2018 Mar 1;9(3):1373-1388

  22. De La Garzall R. Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neuroscience &Biobehavioral Reviews 2005 (29): 4-5: 761-770

  23. Van Lier D, Geven C et al. Experimental human endotoxemia as a model of systemic inflammation. Biochimie. 2019 Apr;159:99-106

  24. Schedlowski M, Engler H et al. Endotoxin-induced experimental systemic inflammation in humans: A model to disentangle immune-to-brain communication. Brain, Behavior, and Immunity 2015 (35): 1-8

  25. Aitken AE, Richardson TA et al. Regulation of drug-metabolizing enzymes and transporters in inflammation. Annu Rev Pharmacol Toxicol 2006: 46:123–149

  26. Bolder U, Ton-Nu HT et al. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology 1997: 112:214–225.

  27. Cherrington NJ, Slitt AL et al. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug MetabDispos2004: 32:734–741

  28. Tang W, Yi C et al. Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats. 2000 Mol Cell Biol Res Commun 4:90–97

  29. Nolan JP. The contribution of gut-derived endotoxins to liver injury. The Yale Journal of Biol and Med. 1979. (52): 127-133

  30. Ganey PE, Roth RA. Concurrent inflammation as a determinant of susceptibility to toxicity from xenobiotic agents. Toxicology. 2001 Dec 28;169(3):195-208. Review.

  31. Ditter B, Urbaschek R. Ability of various adsorbents to bind endotoxins in vitro and to prevent orally induced endotoxemia in mice. Gastroenterology 1983; 84:1547-52

  32. Maklad A, Emara A et al. Pediatric poisoning in Egypt. Journal of Applied Pharmaceutical Science, 2012 2 (2): 1-6.

  33. Khalid J, Zailaey A. Medical and environmental applications of activated charcoal: review article. European Scientific Journal January 2015 (11): 3: 50-56

  34. Neuvonen J, Olkkola KT. Oral activated charcoal in the treatment of intoxications: role of single and repeated doses. Med Toxicol, 1988: 3; 33-58

  35. Karnib M, Kabbani A et al. Heavy metals removal using activated carbon, silica and silica activated carbon composite. Energy Procedia 2014: 50, 113 – 120.

  36. Du XN, Niu Z et al. Effect of activated charcoal on endotoxin adsorption. Part I. An in vitro study. Biomater Artif Cells Artif Organs. 1987;15(1):229-35

  37. Dalefield R. Emergency care and stabilization of the poisoned patient. In: Veterinary Toxicology for Australia and New Zealand, 2017: 19-32

  38. Rodriguez-Reinoso. Activated carbon and adsorption. in Encyclopedia of Materials: Science and Technology, 2001: 22-24

  39. Krasopoulos JC, De Bari VA et al The adsorption of bile salts on Lipids. 1980 May;15(5):365-70

  40. Neuvonen PJ, Kuusisto P. Activated charcoal in the treatment of hypercholesterolaemia: dose-response relationships and comparison with cholestyramine Eur J Clin Pharmacol. 1989;37(3):225-30

  41. Musso CG, Michelangelo H et al. Combination of oral activated charcoal plus low protein diet as a new alternative for handling in the old end-stage renal disease patients Saudi J Kidney Dis Transpl. 2010 Jan;21(1):102-4

  42. Koide, S. S. Chitin-chitosan: properties, benefits and risks. Nutrition Research 1998;8(6):1091-1101

  43. Macchi G. A new approach to the treatment of obesity: chitosan’s effects on body weight reduction and plasma cholesterol levels. Acta Toxicol Ther 1996;17:303-320

  44. Lütjohann D, Marinova M. Nutrients. Influence of Chitosan Treatment on Surrogate Serum Markers of Cholesterol Metabolism in Obese Subjects. 2018 Jan 11;10(1)

  45. Maezaki Y, Tsuji K et al. Hypocholesterolaemic effect of chitosan in adult males. Biosc Biochem Biotech 1993;57:1439-1444

  46. Zhang L, Zeng Y.  Removal of heavy metal ions using chitosan and modified chitosan: A review. Journal of Molecular Liquids 2016: 214; 175-191

  47. Ahmad M, Manzoor K. Versatile nature of hetero-chitosan based derivatives as biodegradable adsorbent for heavy metal ions; a review. J BiolMacromol. 2017 Dec;105(Pt 1):190-203

  48. Xiao DF, Tang ZR et al. Effects of dietary administering chitosan on growth performance, jejunal morphology, jejunal mucosal sIgA, occluding, claudin-1 and TLR4 expression in weaned piglets challenged by enterotoxigenic Escherichia coli. Int. Immunopharmacol. 2016: 17; 670–676

  49. Guan G, Azad MAK et al. Biological effects and applications of chitosan and chito-oligosaccharides. Front. Physiol. 2019 May 7;10:516

  50. Wan J, Yang KY et al. Dietary chitosan oligosaccharide supplementation improves foetal survival and reproductive performance in multiparous sows. RSC Adv. 2016: 6;70715–70722

  51. Shoemaker, RC. (2001) Desperation Medicine. Gateway Press: Baltimore. 2. Shoemaker, RC, Schaller J, Schmidt P. (2005) Mold Warriors: Fighting America’s Hidden Threat. Gateway Press: Baltimore

  52. Karunasena E, Larrañaga MD et al. Building-Associated neurological damage modeled in human cells: a mechanism of neurotoxic effects by exposure to mycotoxins in the indoor environment. Mycopathologia. 2010 Dec;170(6):377-90

  53. Carretero MI. Clay minerals and their beneficial effects upon human health. A review. Appl Clay Sci 2002; 21: 155–63.

  54. Herrera P, Burghardt RC et al. Adsorption of Salmonella enteritidis by cetylpyridinium-exchanged montmorillonite clays. Vet Microbiol 2000; 74: 259–72

  55. Haydel SE, Remenih CM. J Broad-spectrum in vitro antibacterial activities of clay minerals against antibiotic-susceptible and antibiotic-resistant bacterial pathogens Antimicrob Chemother. 2008 Feb;61(2):353-61

  56. Schaumberger S, Ladining A et al. Evaluation of the endotoxin binding efficiency of clay minerals using the Limulus Amebocyte lysate test: an in vitro study. MB Express. 2014; 4: 1

  57. Wortelboer HM, Balvers MG et al. Glutathione-dependent interaction of heavy metal compounds with multidrug resistant proteins MRP1 and MRP2. Environmental Toxicology and Pharmacology 2008, 26, 102-108.

  58. Nadarajah V, Neiders ME et al. Localized cellular inflammatory responses to subcutaneously implanted dental mercury. Journal of Toxicology and Environmental Health 1996, 49, (2), 113-126(14).

  59. Bland, Jeffrey. Effect of orally consumed Aloe vera Juice on Gastrointestinal Function in Normal Humans. Preventative Medicine, March-April 1985

  60. Marzorati M. In vitro modulation of the human gastrointestinal microbial community by plant-derived polysaccharide-rich dietary supplements. Int J Food Microbiol. 2010 May 15;139(3):168-76.

  61. Im SA, Lee YR et al. In vivo evidence of the immunomodulatory activity of orally administered Aloe vera gel. Arch Pharm Res. 2010 Mar;33(3):451-6.

  62. Visuthikosol V, Chowchuen B et al. Effect of aloe vera gel to healing of burn wound a clinical and histologic study. J Med Assoc Thai. 1995 Aug;78(8):403-9

  63. Im SA, Oh ST et al. Identification of optimal molecular size of modified Aloe polysaccharides with maximum immunomodulatory activity. International Immunopharmacology. 2005;5(2):271-279

  64. Hu Y, Xu J, Hu Q. Evaluation of antioxidant potential of aloe vera (Aloe barbadensis miller) extracts. J Agric Food Chem. 2003 Dec 17;51(26):7788-91

  65. Eshun, K., He, Q. Aloe vera: a valuable ingredient for the food, pharmaceutical and cosmetic industries—a review. Crit. Rev. Food Sci. Nutr. 2004: 44, 91–96

  66. Mohamed RE, Gadour MO. The lowering effect of Gum Arabic on hyperlipidemia in Sudanese patients. Front Physiol. 2015 May 18;6:160

  67. Eswaran S, Muir J et al. Fiber and functional gastrointestinal disorders. Am J Gastroenterol. 2013 May;108(5):718-27

  68. Silva FM, Kramer CK et al. Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. Nutr Rev. 2013 Dec;71(12):790-801

  69. Chutkan R, Fahey G. Viscous versus nonviscous soluble fiber supplements: mechanisms and evidence for fiber-specific health benefits. J Am Acad Nurse Pract. 2012 Aug;24(8):476-87

  70. Crociani F, Alessandrini A et al. Degradation of complex carbohydrates by Bifidobacterium spp. Int.J Food Microbiol. 1994;24:199-210.

  71. Walter DJ, Eastwood MA et al. Fermentation of wheat bran and gum arabic in rats fed on an elemental diet. Br.J.Nutr. 1988;60:225-32

  72. Wyatt GM, Bayliss CE et al. A change in human faecal flora in response to inclusion of gum arabic in the diet. Br.J.Nutr. 1986;55:261-6.

  73. Daguet D, Pinheiro I et al. Arabinogalactan and fructooligosaccharides improve the gut barrier function in distinct areas of the colon in the Simulator of the Human Intestinal Microbial Ecosystem. J.Fuct. Foods, 2016;20:369-79

     

     

0
    0
    Your Cart
    You're 99.00 away from free shipping.
    Your cart is empty
      Calculate Shipping
      Apply Coupon

      to your account for access to our

      Memorial Day

      Weekend Sale!

      Don’t have an account? Sign up here!